ANTIRETROVIRAL THERAPY PARTIALLY RESTORES PHENOTYPIC AND METABOLIC IMMUNOSENESCENCE FEATURES OF T CELLS IN HIV INFECTED INDIVIDUALS

Ageing Curtails the Diversity and Functionality of Nascent CD8+ T Cell Responses against SARS-CoV-2

Focus group study on perceptions and information needs regarding vaccines targeting the older population: a cross-country comparison in four European countries

Effects of the age of vaccination on the humoral responses to a human papillomavirus vaccine

Novel Chitosan-Based Schiff Base Compounds: Chemical Characterization and Antimicrobial Activity

Altered Basal Lipid Metabolism Underlies the Functional Impairment of Naive CD8+ T Cells in Elderly Humans

Editorial: The Role of Systemic and Cellular Metabolism on Susceptibility to Infections and Responsiveness to Vaccination

Kaposi's Sarcoma Lesion Progression in {BKV}-Tat Transgenic Mice Is Increased by Inflammatory Cytokines and Blocked by Treatment with Anti-Tat Antibodies

Vaccine development for herpes simplex viruses: A commentary of special issue editors

Impaired Priming of SARS-CoV-2-Specific Naive CD8+ T Cells in Older Subjects

Use of a Novel Peptide Welding Technology Platform for the Development of B- and T-Cell Epitope-Based Vaccines

Age-related decline of de novo T cell responsiveness as a cause of COVID-19 severity

Hpv-specific systemic antibody responses and memory b cells are independently maintained up to 6 years and in a vaccine-specific manner following immunization with cervarix and gardasil in adolescent and young adult women in vaccination programs in Italy

The Tat Protein of HIV-1 Prevents the Loss of HSV-Specific Memory Adaptive Responses and Favors the Control of Viral Reactivation

In Chronic Hepatitis C Infection, Myeloid-Derived Suppressor Cell Accumulation and T Cell Dysfunctions Revert Partially and Late After Successful Direct-Acting Antiviral Treatment

Naïve CD8+ T-Cells Engage a Versatile Metabolic Program Upon Activation in Humans and Differ Energetically From Memory CD8+ T-Cells

The HIV-1 Tat protein affects human CD4+ T cell programming and activation, and favors the differentiation of naïve CD4+ T cells

Systemic immunodominant CD8 responses with an effector-like phenotype are induced by intravaginal immunization with attenuated HSV vectors expressing HIV Tat and mediate protection against HSV infection

Effects of different routes of administration on the immunogenicity of the Tat protein and a Tat-derived peptide

HIV-1 Tat affects the programming and functionality of human CD8⁺ T cells by modulating the expression of T-box transcription factors